Sign in

You're signed outSign in or to get full access.

Elizabeth C. Bogan

Trustee at GABELLI UTILITY TRUST
Board

About Elizabeth C. Bogan

Independent Trustee of The Gabelli Utility Trust (GUT) since May 16, 2018; year of birth 1944; nominated to serve a new three‑year term through the 2028 Annual Meeting. Former Senior Lecturer in Economics at Princeton University (1992–2020) and former Chair of the Economics & Finance Department at Fairleigh Dickinson University; degrees in Economics from Wellesley (BA), University of New Hampshire (MA, Quantitative Economics), and Columbia University (PhD). Oversees 12 portfolios across the Gabelli Fund Complex; serves on boards of other funds in the Complex. Independence affirmed under 1940 Act/NYSE guidelines; no disclosed interests in the Adviser or its affiliates as of Dec 31, 2024.

Past Roles

OrganizationRoleTenureCommittees / Impact
Princeton UniversitySenior Lecturer in Economics1992–2020Teaching/research in economics; senior academic appointment
Fairleigh Dickinson UniversityChair, Economics & Finance Department; Executive Committee member (College of Business Administration)Not datedDepartment leadership; governance on Executive Committee

External Roles

OrganizationRoleTenureNotes
Gabelli Fund Complex (other registered funds)Trustee/DirectorOngoingServes on boards of other funds within the Complex
Other public company boards (past 5 years, excluding fund Complex)None disclosed for Dr. Bogan

Board Governance

  • Board classification and tenure: Trustee since May 16, 2018; nominated for re‑election to serve until the 2028 Annual Meeting. The Board has 12 Trustees, 10 independent.
  • Committee assignments: Dr. Bogan is not listed among members or chairs of the Audit Committee (Enright—Chair; Birch; Melarkey) or Nominating Committee (Zizza—Chair; Conn; Enright); no other committee assignments for her are disclosed.
  • Independence determination: Independent Trustee under 1940 Act/NYSE definitions; proxy states independent trustees (with noted exceptions, none applicable to Bogan) had no interests in the Adviser or its affiliates as of Dec 31, 2024.
  • Attendance and engagement: Board met four times in FY 2024; each Trustee then serving attended at least 75% of Board meetings and applicable committee meetings. Trustees/nominees did not attend the May 13, 2024 annual meeting (Fund does not expect Trustees to attend).
  • Lead Independent Trustee and executive sessions: James P. Conn serves as Lead Independent Trustee; independent Trustees meet regularly in executive session and chair all Board committees.

Fixed Compensation

Component (FY 2024)Amount (USD)Notes
Annual retainer (Independent Trustee)$6,000Standard cash retainer for independent Trustees
Board meeting fees$1,500 per meetingFour regular quarterly meetings held in FY 2024
Committee meeting fee (member)$1,000 per committee meetingApplies if serving on a committee (no committee service disclosed for Bogan)
Committee chair feesAudit Chair $3,000; Nominating Chair $2,000Not applicable to Bogan; she is not a chair
Aggregate compensation from GUT (Bogan)$12,000Fund‑level compensation paid in FY 2024
Aggregate compensation from Fund Complex (Bogan)$152,000Compensation across 12 funds in the Complex, FY 2024

Performance Compensation

Metric / InstrumentDetail
Cash bonus / target bonusNone disclosed for Trustees; compensation is retainers and meeting fees
Stock awards (RSUs/PSUs)None disclosed for Trustees
Option awardsNone disclosed for Trustees
Performance metrics (TSR, EBITDA, ESG, etc.)None disclosed for Trustee compensation
Vesting schedules / datesNot applicable (no equity awards disclosed)
Severance / change‑of‑control provisionsNot disclosed for Trustees
Clawbacks / tax gross‑upsNot disclosed for Trustees

Other Directorships & Interlocks

CategoryEntityRolePotential Interlock / Conflict
Other registered fundsGabelli Fund Complex (various)Trustee/DirectorSame adviser across Complex; independence preserved; no Bogan‑specific affiliate interests disclosed
Public company boardsNone disclosed for Bogan

Context: Proxy notes certain other Trustees (not Bogan) had interests in entities that may be deemed under common control with the Adviser (e.g., Fahrenkopf, Birch, Zizza), and one Trustee (Zizza) settled an SEC inquiry in 2015—Board determined it does not disqualify him. No such items are disclosed for Bogan.

Expertise & Qualifications

  • PhD economist with long academic tenure (Princeton Senior Lecturer 1992–2020); prior department chair and academic governance experience.
  • Degrees: BA (Wellesley), MA Quantitative Economics (University of New Hampshire), PhD Economics (Columbia).
  • Oversees 12 portfolios within the Gabelli Fund Complex, indicating broad fund governance exposure.

Equity Ownership

MeasureValueAs ofNotes
Common shares owned (GUT)0Dec 31, 2024Less than 1% of shares outstanding
Percent of shares outstanding (GUT)* (<1%)Dec 31, 2024Asterisk denotes <1%
Dollar range in GUTA (None)Dec 31, 2024Proxy dollar range classification
Aggregate dollar range in Fund ComplexE (Over $100,000)Dec 31, 2024Holdings across related funds
Pledged / hedged sharesNone indicatedDec 31, 2024No pledging/hedging disclosures for Bogan

Insider Trades

PeriodForm 3/4/5 ComplianceNotes
FY 2024CompliantBased on review of electronically filed Forms 3 and 4 in FY 2024, applicable persons complied with Section 16(a); proxy does not enumerate any Bogan‑specific transactions.

Governance Assessment

  • Strengths:
    • Independence: Independent Trustee with no disclosed interests in Adviser/affiliates; independent committee governance overall; regular executive sessions.
    • Credentials: PhD economist with decades of academic leadership—useful for oversight of financial reporting and policy matters.
    • Attendance: Met ≥75% threshold in FY 2024; Board met quarterly.
  • Watch items / RED FLAGS:
    • Low fund‑level ownership alignment: 0 GUT shares and “None” dollar range in GUT; while she holds >$100k across the Fund Complex, lack of direct GUT ownership may be viewed as weak alignment.
    • Shareholder engagement signal: No Trustees/nominees attended the May 13, 2024 annual meeting (Fund does not expect attendance), which can be perceived as lower direct engagement with shareholders.
    • Committee influence: Bogan is not listed on Audit or Nominating Committees and holds no chair roles; limited disclosed committee footprint may reduce direct impact on key oversight levers.

Overall: Dr. Bogan brings strong economic and academic governance experience and is independent; however, absence of GUT share ownership and no disclosed committee roles are notable alignment/engagement considerations for investors.